The aesthetic injectables market involves botulinum toxin and dermal fillers that are used to reduce or reverse the signs of facial aging, smoothing of wrinkles, enhancing lips, restoring volume and contours in the face and hands. Aesthetic injectables seek to achieve cosmetic goals through minimally invasive techniques and provide a temporary reduction in the appearance of wrinkles and folds.

The Global Aesthetic Injectables Market is estimated to be valued at US$ 19.76 Bn in 2024 and is expected to exhibit a CAGR of 11% over the forecast period 2024 to 2031.

Key takeaways
Key players operating in the aesthetic injectables are AbbVie, Galderma, Merz Pharma, Teoxane Laboratories, Sinclair Pharma, Suneva Medical, Croma-Pharma GmbH, Luminera Derm, Johnson Johnson, Revance Therapeutics, Hyaltech Ltd, Bioxis Pharmaceuticals, Prollenium Medical Technologies, SciVision Biotech Inc., and Bloomage BioTechnology Corporation Ltd. The rising demand for minimally invasive facial aesthetics and focus on personal care and appearance have boosted the aesthetic injectables market. New product launches and technological advancements have further fueled market growth.

The growing demand for non-surgical Aesthetic Injectables Market Size treatments among millennials and working professionals due to increasing disposable income and investment in personal well-being has driven significant growth. Social media influence and rising self-esteem issues have contributed to the surging demand for aesthetic procedures. Technological advancements including injections laced with vitamins, hyaluronic acids, and specialty designed dermal fillers catering to customized treatment needs have popularized aesthetic injectables.

Market Trends
The preference for minimally invasive procedures over surgical interventions is a key trend in the market. Procedures such as mesotherapy, thread lifts, and liquid facelifts utilizing dermal fillers are gaining traction. These enable gradual non-surgical rejuvenation and lifting of tissues without conventional treatments and associated risks. The demand for natural-looking results is another prominent trend with manufacturers introducing natural looking filler lines and toxin variants.

Market Opportunities
The growing medical tourism industry in developing nations provides lucrative opportunities. Procedures such as vampire facelift combining PRP (platelet-rich plasma) therapy and dermal fillers are gaining popularity. The increasing prominence of social media influencers highlighting aesthetic treatments has made these mainstream and contributed to their acceptance. This has created opportunities for customized localized product launches and optimized treatment protocols.

Impact of COVID-19 on Aesthetic Injectables Market

The COVID-19 pandemic had a significant negative impact on the aesthetic injectables market growth globally. Due to widespread lockdowns and restrictions imposed by governments worldwide in 2020-21, non-essential medical procedures such as cosmetic surgeries and treatments were suspended or postponed. This led to a sharp decline in demand for aesthetic injectables like botox, dermal fillers, and fat reducers during this period. Even after restrictions were eased in late 2021-early 2022, consumer confidence in visiting clinics was still low due to virus fears. This affected the market recovery initially. However, with rapid vaccination drives worldwide, demand started reviving from 2022 onwards. Key players focused on digital marketing promotions to regain consumer trust. They launched new virtual consultation platforms for consultations and treatments. Governments also eased restrictions on aesthetic clinics which further aided market recovery post-pandemic. Though the outbreak had slowed down market growth in short-term, the long-term outlook is positive due to increasing product launches, technological advancements, and rising consumer spending on cosmetic procedures especially among millennials and Gen Z globally.

The North America region accounts for the largest share of the global aesthetic injectables market currently, in terms of value. This is attributed to factors like higher per capita spending on cosmetic treatments, growing popularity of non-surgical procedures, larger number of licensed clinics, technological advancements, and stronger healthcare infrastructure in the region. On the other hand, the Asia Pacific region is projected to witness the fastest growth during the forecast period owing to rapidly growing middle-class demographic with higher disposable incomes, increasing medical tourism, rising adoption of Western beauty standards, and expanding cosmetic industry in the region. This is expected to drive the demand for aesthetic injectables like dermal fillers and botulinum toxin substantially in Asian countries like China, Japan, South Korea and India over the coming years.

The Middle East Africa aesthetic injectables market is also gaining significant growth momentum driven by increasing focus of key industry players. Factors like growing medical tourism hub for cosmetic surgeries due to availability of latest treatments at affordable costs, government initiatives for strengthening healthcare sectors, rising lifestyle diseases, etc. offer immense opportunities for expansion in the MEA region. Overall, developing regions will play a crucial role in shaping the future outlook and dynamics of the global aesthetic injectables industry post-pandemic.

Get more insights on Aesthetic Injectables Market